Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma
- PMID: 29459844
- PMCID: PMC5807339
- DOI: 10.3389/fneur.2018.00033
Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma
Abstract
Advances in metabolic imaging techniques have allowed for more precise characterization of gliomas, particularly as it relates to tumor recurrence or pseudoprogression. Furthermore, the emerging field of radiogenomics where radiographic features are systemically correlated with molecular markers has the potential to achieve the holy grail of neuro-oncologic neuro-radiology, namely molecular diagnosis without requiring tissue specimens. In this section, we will review the utility of metabolic imaging and discuss the current state of the art related to the radiogenomics of glioblastoma.
Keywords: glioma; magnetic resonance spectroscopy; neurooncology; neuroradiology; positron-emission tomography; radiogenomics.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Senft C, Hattingen E, Pilatus U, Franz K, Schänzer A, Lanfermann H, et al. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Neurosurgery (2009) 65(5):908–913; discussion 913.10.1227/01.NEU.0000356982.82378.BA - DOI - PubMed
 
Publication types
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        